Trastuzumab is the first of the monoclonal antibodies to be used in the treatment of those patients who have HER2-positive metastatic breast cancer. It is most effective when combined with ...
Cite this: Trastuzumab as the Lead Monoclonal Antibody in Advanced Breast Cancer: Choosing Which Patient and When - Medscape - Feb 01, 2008. Disclosure: The author has no relevant affiliations or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback